Susquehanna International Group, LLP Fulcrum Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $823 Billion
- Q3 2025
A detailed history of Susquehanna International Group, LLP transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 53,571 shares of FULC stock, worth $464,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,571
Previous 99,490
46.15%
Holding current value
$464,460
Previous $684,000
31.73%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding FULC
# of Institutions
134Shares Held
55.4MCall Options Held
176KPut Options Held
13.5K-
Ra Capital Management, L.P. Boston, MA10.2MShares$88.7 Million1.53% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.38MShares$46.7 Million1.41% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$45.5 Million5.13% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$41.6 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.67MShares$40.5 Million1.65% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $451M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...